Nectar Medipharma Private Limited

Nectar Medipharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24232MH1999PTC243788 Incorporated 28 October 1999 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹6.09 Cr
▼ 1% YoY
Net profit · FY 2025
₹21.96 Lakh
Net margin 3.6%
EBITDA · FY 2025
₹33.09 Lakh
EBITDA margin 5.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
27 yrs
Est. 1999
Directors on board
5
As per MCA filings
Active GSTINs
2
GST registered

About Nectar Medipharma Private Limited

Data last updated:

Nectar Medipharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH1999PTC243788. Its GSTIN is 23AABCN2369P1Z5 (Madhya Pradesh). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kruti Jigar Bathia and Shweta Nipun Sanghavi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 204A Janki Centre 2nd Floor Jeevan Nagar Off. Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.09 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹21.96 Lakh (net margin 3.6%) and EBITDA of ₹33.09 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.

Court records list 1 case involving the company, including 1 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232MH1999PTC243788
Registration Number 243788
Incorporation Date 28 October 1999
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Nectar Medipharma has one previous CIN (Corporate Identification Number): U24232RJ1999PTC015964. The current CIN is U24232MH1999PTC243788, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232MH1999PTC243788Current
U24232RJ1999PTC015964Previous

Contact details

Nectar Medipharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    No. 204A Janki Centre 2nd Floor Jeevan Nagar Off. Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Nectar Medipharma Private Limited, buy the company report.

Comprehensive company report
Nectar Medipharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Nectar Medipharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Nectar Medipharma Private Limited, buy the company report.

Financials of Nectar Medipharma Private Limited

FY 2025 filings available

Nectar Medipharma Private Limited reported revenue of ₹6.09 Cr (down 1% YoY) for FY 2025.

Revenue · FY 2025
₹6.09 Cr ▼ 1%
Net profit · FY 2025
₹21.96 Lakh margin 3.6%
EBITDA · FY 2025
₹33.09 Lakh margin 5.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 4%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 31%
5 years · compounded
▲ 25%

Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹33.09 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹21.96 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.4%
Net Profit Margin3.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nectar Medipharma Private Limited, buy the company report.

Board of directors of Nectar Medipharma Private Limited

Nectar Medipharma has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kruti Jigar BathiaDirector15 Jan 201511 Years 10 MonthsCurrent
Shweta Nipun SanghaviDirector15 Jan 201511 Years 10 MonthsCurrent
Ashish Subhashbhai DesaiDirector14 Jul 201115 Years 4 MonthsCurrent
Jayendra Natverlal DesaiDirector19 Nov 20206 Years 0 MonthsCurrent
Gunjan Ashokbhai DesaiDirector14 Oct 201412 Years 1 MonthsCurrent

Auditor

Nectar Medipharma Private Limited is audited by UMESH SHAH & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
UMESH SHAH & ASSOCIATESFY 2019114563W

Shareholding

The shareholding of Nectar Medipharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nectar Medipharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nectar Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Nectar Medipharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
23AABCN2369P1Z5Madhya PradeshActive01 Jul 2017
24AABCN2369P1Z3GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Nectar Medipharma Private Limited, buy the company report.

Recent activity

Nectar Medipharma Private Limited has 10 board changes on record since 2011: 5 appointments and 5 cessations. The latest: Jayendra Natverlal Desai ceased to be Additional Director on 29 Nov 2021.

AGM
Nectar Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nectar Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Jayendra Natverlal Desai ceased to be Additional Director.
Appointed
Jayendra Natverlal Desai was appointed as Director.
Ceased
Gunjan Ashokbhai Desai ceased to be Additional Director.
Appointed
Kruti Jigar Bathia was appointed as Director.
Appointed
Shweta Nipun Sanghavi was appointed as Director.
Ceased
Bharat Balkrishnan Shah ceased to be Director.
Appointed
Gunjan Ashokbhai Desai was appointed as Director.
Ceased
Jacob Thomas ceased to be Director.
Ceased
Pankaj Agrawal ceased to be Director.
Appointed
Ashish Subhashbhai Desai was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Nectar Medipharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 1999 (27+ years old) and is registered under CIN U24232MH1999PTC243788.

Nectar Medipharma has 5 current directors:

The latest financial statements of Nectar Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nectar Medipharma is 23AABCN2369P1Z5, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCN2369P1Z3 (Gujarat).

The CIN (Corporate Identification Number) of Nectar Medipharma is U24232MH1999PTC243788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nectar Medipharma has 1 court case on record: 1 filed against it.

Nectar Medipharma was incorporated on 28 October 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.

Jayendra Natverlal Desai ceased to be Additional Director on 29 Nov 2021. Jayendra Natverlal Desai was appointed as Director on 19 Nov 2020. Gunjan Ashokbhai Desai ceased to be Additional Director on 30 Sep 2015. Nectar Medipharma has 10 board changes on record in total.

The registered office of Nectar Medipharma is at No. 204A Janki Centre 2nd Floor Jeevan Nagar Off. Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053.

Nectar Medipharma operates in the pharma industry, in the drug formulation and development segment.